Design Therapeutics, Inc.
DSGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$17 | -$19 | -$18 | -$14 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $4 | $3 |
| Change in WC | $3 | $1 | -$2 | $2 |
| Other Non-Cash | $3 | $3 | -$1 | -$1 |
| Operating Cash Flow | -$11 | -$14 | -$17 | -$10 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$78 | -$40 | -$87 | -$64 |
| Inv. Sales/Matur. | $85 | $60 | $94 | $66 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $7 | $20 | $8 | $2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$5 | $6 | -$9 | -$8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20 | $14 | $23 | $30 |
| End Cash | $15 | $20 | $14 | $23 |
| Free Cash Flow | -$11 | -$15 | -$17 | -$10 |